对阿尔茨海默病和抑郁症的图书统计分析
Sixin Li1,2, Qian Zhang3,4, Jian Liu5
1Department of Psychiatry, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Current neuropharmacology
|August 2, 2024
概括
这种图书统计分析显示,越来越多的研究重点集中在阿尔茨海默病和抑郁症上. 关键主题包括疾病机制,早期检测和改善患者的生活质量.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 精神病学是一个精神病学.
背景情况:
- 阿尔茨海默病 (AD) 和抑郁症之间确立的联系.
- 需要了解AD抑郁症研究中的研究格局和关键主题.
研究的目的:
- 对阿尔茨海默病与抑郁症相关的研究进行文献分析.
- 确定主要的贡献者和普遍的研究主题.
主要方法:
- 科学网络核心集合 (1991-2023) 的文献搜索.
- 使用微软Excel,VOSviewer和CiteSpace.Space进行图书统计分析.
- 确定贡献的国家,机构,作者和期刊.
主要成果:
- 分析了10,553篇文章;美国,中国和英国是出版量最高的地区.
- 多伦多大学和匹兹堡大学是领先的机构.
- 关键主题包括AD机制,早期检测,生活质量和神经精神病症状管理.
结论:
- 对阿尔茨海默氏症和抑郁症的研究表明,这种趋势正在上升.
- 未来的研究应该集中在已识别的流行主题上,以促进理解.
- 局限性包括潜在的选择和语言偏差,因为单个数据库和仅英语标准.
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Depressive Disorders: Etiology
60
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
60
Depression: Overview
230
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
230


